Abital Pharma Pipelines Ltd. is an Israel-based Pharma Accelerator owned by Prof. Moussa B.H. Youdim, focused on developing novel CNS disease therapies and propriety mRNA Biomarkers.

Our mission is to develop novel technologies for medical unmet needs We engage in innovative Drug Device Combination, Biomarker diagnostic kits, drug combinations, drug repositioning and targeted drug delivery.

Abital's portfolio includes, but is not limited, to:

Abital's pipeline relates to the following fields:
Neurodegeneration Disorders and Aging, Pain Therapy, ALS, Autism.